Article Type
Original Research
Published
The objective of this study performed in Brazil was to understand the real-life efficacy and safety of using dupilumab in patients with moderate or severe atopic dermatitis.
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.